Essential medicines and health products

Fair pricing of medicines

WHO

A fair price is one that is affordable for health systems and patients and that at the same time provides sufficient market incentive for industry to invest in innovation and the production of medicines. In this context, fairness implies positive incentives/benefits for all stakeholders, including purchasers and those involved in the research and development and manufacture of medicines.

Fair pricing forum

The Forum is taking place in Amsterdam, the Netherlands, on 11 May 2017, and is co-sponsored by the Dutch Ministry of Health, Welfare and Sport and WHO.

Fair pricing Q&A

Contact

Andrew Rintoul
Innovation, Access and Use
rintoula@who.int

Advisory Group Meeting

The informal WHO Advisory Group meeting on fair pricing was held on 22-24 November 2016. The meeting was held to discuss challenges in the current system of pricing medicines and provide advice to WHO on how to move forward with organizing the Fair Pricing Forum.